New IBD insights; Adding antiangiogenesis drugs amps up efficacy of radiation therapy;

> Scientists at Beth Israel Deaconess Medical Center have been studying the role an immunosuppressive pathway plays in IBD. Release

> A team at Massachusetts General Hospital says that adding antiangiogenesis drugs may "improve the effectiveness of radiation treatment of nervous system tumors that interfere with the hearing of patients with the genetic disorder neurofibromatosis 2." Release

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.